Literature DB >> 28481927

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.

Li-Han Chin, Sung-Po Hsu, Wen-Bin Zhong, Yu-Chih Liang.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0118674.].

Entities:  

Year:  2017        PMID： 28481927      PMCID： PMC5421810          DOI： 10.1371/journal.pone.0177545

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


There is an error in affiliation 2 for authors Sung-Po Hsu and Wen-Bin Zhong. Affiliation 2 should be: Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  1 in total

1.  Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.

Authors:  Li-Han Chin; Sung-Po Hsu; Wen-Bin Zhong; Yu-Chih Liang
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240
  1 in total
  1 in total

1.  A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model.

Authors:  Wen-Bin Zhong; Yuan-Chin Tsai; Li-Han Chin; Jen-Ho Tseng; Li-Wen Tang; Steve Horng; Yu-Ching Fan; Sung-Po Hsu
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.